Prevention nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and adolescents from the age of 12.
APREPILOR TRIO 125 mg/80 mg is given as part of combination therapy (see Dosage & Administration).
Other Services
Country
Account